The chart below shows the treatments the participants took.
Acalabrutinib and BSC BSC only
89 participants 88 participants
• 100 mg of acalabrutinib • BSC as decided by the
as a capsule by mouth study doctors
• BSC as decided by the
study doctors
• acalabrutinib twice a day • BSC as decided by the
for 10 days study doctors
• BSC as decided by the
study doctors
What happened during this study?
The participants were in the study for about 3.5 months. But, the entire study took
5 months to finish.
The study started in June 2020 and ended in November 2020.
7 | Clinical Study Results